AWAKE BRAIN SURGERY IN A PATIENT WITH GLIOBLASTOMA
DOI:
https://doi.org/10.67214/xntyfn76Keywords:
Asleep-awake-asleep technique, Awake brain surgery, glioblastomaAbstract
The awake craniotomy, as a surgical procedure, facilitates maximal resection of brain tumors with minimal or no damage to eloquent brain areas. Conscious sedation and asleep-awake- asleep techniques are two anesthetic techniques employed. During the awake phase, the pa- tient should be alert and cooperative, with adequate analgesia as an essential component of the anesthetic management while neurological testing is performed. Ensuring airway patency, proper oxygenation and ventilation, avoidance of hypoxia and hypercarbia, and maintaining stable systemic and cerebral hemodynamics are crucial. We present a case of a right-handed 56-years-old man with speech difficulties manifested as fluent dysphasia and magnetic reso- nance findings of intra-axial supratentorial left-sided temporoparietal lesions. The patient was scheduled for awake brain surgery according to the affected eloquent language brain area of the dominant hemisphere. Asleep-awake-asleep anesthetic technique was utilized. Short-acting sedative agents propofol and dexmedetomidine were used, along with remifentanil and fentanyl as analgesics. After awakening, neurological testing of sensory, motor and cognitive functions was performed, revealing no new neurological deficits and achieving maximally safe micro- surgical tumor resection with stable hemodynamics and no respiratory or intracranial adverse events. With histopathological findings of glioblastoma (WHO Grade IV), chemotherapy and radiotherapy followed the surgery. The available literature demonstrates the importance of the extent of tumor resection for improved outcomes and survival benefits in glioma surgery, with maximal resection without excising functional brain tissue, being the primary goal of awake brain surgery.
Downloads
References
1. Piccioni F, Fanzio M. Management of anesthesia in awake craniotomy. Minerva Anestesiol. 2008;74(7-8):393-408.
2. P.H. Manninen, T.Y. Yeoh. Awake Craniotomy. Essentials of Neuroanesthesia. Elsevier. Inc. Academic Press. 2017, Pages 489-501. http://dx.doi.org/10.1016/B978-0-12-805299-0.00029-4.
3. Dziedzic, T., & Bernstein, M. (2014). Awake craniotomy for brain tumor: indications, technique, and benefits. Expert Review of Neurotherapeutics, 14(12), 1405–1415. https://doi.org/10.1586/14737175.2014.979793.
4. Capelle L, et al. Spontaneous and therapeutic prognostic factors in adult hemispheric World Health Organization Grade II gliomas: a series of 1097 cases: clinical article. J Neurosurg. 2013;118(6):1157–1168.
5. Lacroix M, et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, the extent of resection, and survival. J Neurosurg. 2001;95(2):190–198.
6. Sanai N, et al. An extent of resection threshold for newly diagnosed glioblastomas. J Neurosurg. 2011;115(1):3–8.
7. Smith JS, et al. Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas. J Clin Oncol. 2008;26(8):1338–1345.
8. Singh K, Dua A. Anesthesia for Awake Craniotomy. [Updated 2023 Jul 6]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK572053/.
9. Han Q, Liang H, Cheng P, Yang H, Zhao P. Gross Total vs. Subtotal Resection on Survival Outcomes in Elderly Patients With High-Grade Glioma: A Systematic Review and Meta-Analysis. Front Oncol. 2020 Mar 18;10:151. doi: 10.3389/fonc.2020.00151. PMID: 32257941; PMCID: PMC7093492.
10. Brown TJ, Brennan MC, Li M, Church EW, Brandmeir NJ, Rakszawski KL, Patel AS, Rizk EB, Suki D, Sawaya R, Glantz M. Association of the Extent of Resection With Survival in Glioblastoma: A Systematic Review and Meta-analysis. JAMA Oncol. 2016 Nov 1;2(11):1460-1469. doi: 10.1001/jamaoncol.2016.1373. PMID: 27310651; PMCID: PMC6438173.
11. Fiore G, Abete-Fornara G, Forgione A, Tariciotti L, Pluderi M, Borsa S, Bana C, Cogiamanian F, Vergari M, Conte V, Caroli M, Locatelli M, Bertani GA. Indication and eligibility of glioma patients for awake surgery: A scoping review by a multidisciplinary perspective. Front Oncol. 2022 Sep 21;12:951246. doi: 10.3389/fonc.2022.951246. PMID: 36212495; PMCID: PMC9532968.
12. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO; European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005 Mar 10;352(10):987-96. doi: 10.1056/NEJMoa043330. PMID: 15758009.
13. Gerritsen JKW, Zwarthoed RH, Kilgallon JL, Nawabi NL, Jessurun CAC, Versyck G, Pruijn KP, Fisher FL, Larivière E, Solie L, Mekary RA, Satoer DD, Schouten JW, Bos EM, Kloet A, Nandoe Tewarie R, Smith TR, Dirven CMF, De Vleeschouwer S, Broekman MLD, Vincent AJPE. Effect of awake craniotomy in glioblastoma in eloquent areas (GLIOMAP): a propensity score-matched analysis of an international, multicentre, cohort study. Lancet Oncol. 2022 Jun;23(6):802-817. doi: 10.1016/S1470-2045(22)00213-3. Epub 2022 May 12. PMID: 35569489.
14. Ramakrishnan PK, Saeed F, Thomson S, Corns R, Mathew RK, Sivakumar G. Awake craniotomy for high-grade gliomas - a prospective cohort study in a UK tertiary-centre. Surgeon. 2024 Feb;22(1):e3-e12. doi: 10.1016/j.surge.2023.11.002. Epub 2023 Nov 25. PMID: 38008681.
15. Garavaglia MM, Das S, Cusimano MD, Crescini C, Mazer CD, Hare GMT, Rigamonti A. Anesthetic approach to high-risk patients and pro-longed awake craniotomy using dexmedetomidine and scalp block. J Neurosurg Anesthesiol 2014; 26:226–33. (contr)
16. Hervey-Jumper SL, Li J, Lau D, Molinaro AM, Perry DW, Meng L, Berger MS. Awake craniotomy to maximize glioma resection: methods and technical nuances over 27 years. J Neurosurg 2015; 123:325–39.
17. Brown T, Shah AH, Bregy A, Shah NH, Thambuswamy M, Barbarite E, Fuhrman T, Komotar RJ. Awake craniotomy for brain tumor resection: the rule rather than the exception? J Neurosurg Anesthesiol. 2013 Jul;25(3):240-7. doi: 10.1097/ANA.0b013e318290c230. PMID: 23603885.
18. Sacko O, Lauwers-Cances V, Brauge D, Sesay M, Brenner A, Roux FE. Awake craniotomy vs surgery under general anesthesia for resection of supratentorial lesions. Neurosurgery. 2011 May;68(5):1192-8; discussion 1198-9. doi: 10.1227/NEU.0b013e31820c02a3. PMID: 21273923.
19. See JJ, Lew TW, Kwek TK, Chin KJ, Wong MF, Liew QY, Lim SH, Ho HS, Chan Y, Loke GP, Yeo VS. Anaesthetic management of awake craniotomy for tumor resection. Ann Acad Med Singap. 2007 May;36(5):319-25. PMID: 17549277.
20. Lechowicz-Głogowska B, Uryga A, Weiser A, Salomon-Tuchowska B, Burzyńska M, Fortuna W, Kasprowicz M, Tabakow P. Awake craniotomy with dexmedetomidine during resection of brain tumors located in eloquent regions. Anaesthesiol Intensive Ther. 2022;54(5):347-356. doi: 10.5114/ait.2022.123151. PMID: 36734444; PMCID: PMC10156559.
21. Nossek E, Matot I, Shahar T, Barzilai O, Rapoport Y, Gonen T, Sela G, Grossman R, Korn A, Hayat D, Ram Z. Intraoperative seizures during awake craniotomy: incidence and consequences: analysis of 477 patients. Neurosurgery 2013; 73:135–40.
22. Piccioni F, Fanzio M. Management of anesthesia in awake craniotomy. Minerva Anestesiol 2008; 74:393–408.
23. Lapointe S, Perry A, Butowski NA. Primary brain tumors in adults. Lancet. 2018 Aug 4;392(10145):432-446. doi: 10.1016/S0140-6736(18)30990-5. Epub 2018 Jul 27. PMID: 30060998.
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain copyright of their work and grant the Macedonian Journal of Anaesthesia the right of first publication.
This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Authors are permitted to enter into separate, additional contractual arrangements for the non-exclusive distribution of the published version of the work, provided that its initial publication in this journal is acknowledged.